What therapy is recommended for immunocompromised patients with herpes zoster (shingles)?

Updated: Feb 11, 2021
  • Author: Camila K Janniger, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Antiviral therapy has been demonstrated to halt progression and dissemination of acute herpes zoster in immunocompromised patients, even when initiated more than 72 hours after rash onset. [106] Accordingly, such therapy is recommended for all immunocompromised patients who present before the full crusting of all lesions.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!